Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro
Authors
Keywords
TDF, FTC, RAL, Neural progenitor cells
Journal
Journal of Neuroimmune Pharmacology
Volume 12, Issue 4, Pages 682-692
Publisher
Springer Nature
Online
2017-07-22
DOI
10.1007/s11481-017-9755-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIV Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz Reduces Neural Stem Cell Proliferation in Vitro and in Vivo
- (2016) Jingji Jin et al. CELL TRANSPLANTATION
- Neurotoxic effects of AZT on developing and adult neurogenesis
- (2015) Meryem Demir et al. Frontiers in Neuroscience
- Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients
- (2015) Leonardo Calza et al. Infectious Diseases
- Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir
- (2014) Erick T Tatro et al. BMC INFECTIOUS DISEASES
- Antiretroviral Treatment of Adult HIV Infection
- (2014) Huldrych F. Günthard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz
- (2014) A. Blas-Garcia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
- (2014) Cagla Akay et al. JOURNAL OF NEUROVIROLOGY
- Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)
- (2014) Vasudev R Rao et al. AIDS Research and Therapy
- Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients
- (2013) Jürgen K. Rockstroh et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways
- (2013) F. B. Del Guerra et al. JOURNAL OF NEUROVIROLOGY
- Cortical lesion stimulates adult subventricular zone neural progenitor cell proliferation and migration to the site of injury
- (2013) Bhaskar Saha et al. Stem Cell Research
- Antiretroviral neurotoxicity
- (2012) Kevin Robertson et al. JOURNAL OF NEUROVIROLOGY
- Generation of HIV Latency in Humanized BLT Mice
- (2011) P. W. Denton et al. JOURNAL OF VIROLOGY
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
- (2010) Robert K. Heaton et al. JOURNAL OF NEUROVIROLOGY
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
- (2009) Christina M Marra et al. AIDS
- Liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study
- (2008) Noel A. Gomes et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Executioner caspase-3 and caspase-7 are functionally distinct proteases
- (2008) J. G. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started